Yesterday, Nov. 16, 2015, 86 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $1,470.50 to $10,820,124.97.

Highlighted Stocks Traded by Insiders:

Cummins (CMI) - FREE Research Report

Di Leo Allen Bruno V, who is Director at Cummins, bought 1,500 shares at $99.52 on Nov. 16, 2015. Following this transaction, the Director owned 2,803 shares meaning that the stake was boosted by 115.12% with the 1,500-share transaction.

The shares most recently traded at $98.81, down $0.71, or 0.72% since the insider transaction. Historical insider transactions for Cummins go as follows:

  • 4-Week # shares sold: 1,958
  • 12-Week # shares sold: 1,958
  • 24-Week # shares sold: 1,958

The average volume for Cummins has been 2.3 million shares per day over the past 30 days. Cummins has a market cap of $17.5 billion and is part of the industrial goods sector and industrial industry. Shares are down 31.24% year-to-date as of the close of trading on Monday.

Cummins Inc. designs, manufactures, distributes, and services diesel and natural gas engines, and engine-related components. It operates in four segments: Engine, Distribution, Components, and Power Generation. The stock currently has a dividend yield of 3.95%. The company has a P/E ratio of 10.6. Currently, there are 6 analysts who rate Cummins a buy, 2 analysts rate it a sell, and 12 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CMI - FREE

TheStreet Quant Ratings rates Cummins as a buy. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures, notable return on equity and attractive valuation levels. We feel its strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full Cummins Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Viper Energy Partners (VNOM) - FREE Research Report

Hollis Michael L., who is Director at Viper Energy Partners, bought 1,500 shares at $15.59 on Nov. 16, 2015. Following this transaction, the Director owned 58,080 shares meaning that the stake was boosted by 2.65% with the 1,500-share transaction.

The shares most recently traded at $15.08, down $0.51, or 3.38% since the insider transaction. Historical insider transactions for Viper Energy Partners go as follows:

  • 4-Week # shares bought: 3,000
  • 12-Week # shares bought: 3,000
  • 24-Week # shares bought: 3,000

The average volume for Viper Energy Partners has been 43,700 shares per day over the past 30 days. Viper Energy Partners has a market cap of $1.2 billion and is part of the basic materials sector and energy industry. Shares are down 18.97% year-to-date as of the close of trading on Monday.

Viper Energy Partners LP owns, acquires, exploits, and develops oil and natural gas properties in North America. The company holds mineral interests covering an area of approximately 14,804 gross acres in the Permian Basin, West Texas; and 10,364 gross acres in the Midland and Delaware basins. The stock currently has a dividend yield of 5.21%. The company has a P/E ratio of 40.4. Currently, there are 4 analysts who rate Viper Energy Partners a buy, no analysts rate it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on VNOM - FREE

TheStreet Quant Ratings rates Viper Energy Partners as a sell. The company's weaknesses can be seen in multiple areas, such as its feeble growth in its earnings per share and generally disappointing historical performance in the stock itself. Get the full Viper Energy Partners Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Healthsouth (HLS) - FREE Research Report

Charbonneau Elissa Joy, who is Chief Medical Officer at Healthsouth, bought 294 shares at $33.68 on Nov. 16, 2015. Following this transaction, the Chief Medical Officer owned 1,490 shares meaning that the stake was boosted by 24.59% with the 294-share transaction.

The shares most recently traded at $33.82, up $0.14, or 0.43% since the insider transaction. Historical insider transactions for Healthsouth go as follows:

  • 4-Week # shares bought: 2,000
  • 4-Week # shares sold: 106
  • 12-Week # shares bought: 2,000
  • 12-Week # shares sold: 106
  • 24-Week # shares bought: 2,000
  • 24-Week # shares sold: 106

The average volume for Healthsouth has been 821,000 shares per day over the past 30 days. Healthsouth has a market cap of $3.1 billion and is part of the health care sector and health services industry. Shares are down 12.06% year-to-date as of the close of trading on Monday.

HealthSouth Corporation owns and operates inpatient rehabilitation hospitals in the United States. The company provides specialized rehabilitative treatment on an inpatient and outpatient basis. The stock currently has a dividend yield of 2.74%. The company has a P/E ratio of 18.1. Currently, there are 6 analysts who rate Healthsouth a buy, 1 analyst rates it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on HLS - FREE

TheStreet Quant Ratings rates Healthsouth as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, notable return on equity, good cash flow from operations and increase in net income. We feel its strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full Healthsouth Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.